Boostrix-Polio

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed, with Inactivated Poliovirus Vaccine (DTaP-IPV) · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Boostrix-Polio, covering 2017-07-05 to 2017-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine [Phase 4]